Carvolix SA (EPA:CVX)
France · Delayed Price · Currency is EUR 3.370
-0.080 (-2.32%)
Apr 2, 2026, 5:35 PM CET
Carvolix Market Cap
Carvolix has a market cap or net worth of €199.65 million as of April 6, 2026. Its market cap has increased by 262.43% in one year.
Market Cap
199.65M
Enterprise Value
217.72M
Revenue
900.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.37
Market Cap Chart
Since June 14, 2021, Carvolix's market cap has increased from 145.31M to 199.65M, an increase of 37.40%. That is a compound annual growth rate of 6.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 199.65M | 193.29% |
| Dec 31, 2025 | 68.07M | 28.15% |
| Dec 31, 2024 | 53.12M | -6.82% |
| Dec 29, 2023 | 57.01M | 86.82% |
| Dec 30, 2022 | 30.52M | -70.47% |
| Dec 31, 2021 | 103.35M | -28.88% |
| Jun 14, 2021 | 145.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 226.54M |
| Median Technologies | 171.25M |
| Guerbet | 114.55M |
| Diagnostic Medical Systems | 32.89M |
| Implanet | 27.51M |
| Novacyt | 27.00M |
| Ikonisys | 22.81M |
| Theraclion | 21.57M |